Cyclophosphamide Injection, Powder, For Solution
Product Images NDC 10019-935

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Cyclophosphamide (NDC 10019-935). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cyclophosphamide Structural Formula (Image 01)

Chemical structure diagram of cyclophosphamide monohydrate showing the phosphorus atom bonded to oxygen, an amine group, and a cyclic ring along with the attached water molecule (H2O).*

FDA Label Image

Cyclophosphamide Intalere Choice Representative Container Lbl 10019-935-25 (Image 02)

Cyclophosphamide 500 mg/vial injection powder for solution label by Baxter Healthcare Company. The label specifies sterile, nonpyrogenic product for parenteral use. Instructions include adding 25 mL of diluent (Sterile Water for Injection or 0.9% Sodium Chloride Injection) and shaking to dissolve. The vial is for single-dose use and storage conditions are noted as 25°C or below. Made in Germany for Intalere Choice.*

FDA Label Image

Representative Cyclophosphamide Intalere Ndc 10019-935-01 Panel 1 (Image 03)

Packaging label for Cyclophosphamide for Injection, USP 500 mg/vial by Baxter Healthcare Company. The label indicates the product is a single dose vial that must be diluted for intravenous infusion or direct injection. It includes storage instructions and cautions that it is a cytotoxic agent, sterile, non-pyrogenic, and for parenteral use only. The label also states the vial contains 500 mg of cyclophosphamide and provides handling directions.*

FDA Label Image

Z:\ni\sgl_spl_2018\cyclophosphamide Anda 040745 Intalere Pkging Update Vv 06042018\ha-80-02-316_panel 2.jpgrepresentative Cyclophosphamide Intalere Ndc 10019-935-01 Panel 2 (Image 04)

Packaging label for Cyclophosphamide for Injection, USP 500 mg per vial, intended for intravenous infusion or direct injection. The label states it is Rx only, for single-dose vial use, and must be diluted before administration. Manufactured for Intalere Choice by Baxter Healthcare Corporation, Deerfield, IL, USA, made in Germany, with NDC 10019-935-01.*

FDA Label Image

Cyclophosphamide Intalere Choice Representative Container Lbl 10019-936-60 (Image 05)

Label for Cyclophosphamide injection powder, USP, 1 gram per vial, manufactured by Baxter Healthcare Company. The label indicates it is a cytotoxic agent for single dose use, sterile, non-pyrogenic, for parenteral use by intravenous or oral routes. Instructions include adding sterile water or sodium chloride injection to dissolve the drug for infusion or direct injection. Storage information and reference to the product insert are also included.*

FDA Label Image

Cyclophosphamide Intalere Representative Carton Lbl 10019-936-01 Panel 1 (Image 06)

The label for Cyclophosphamide for Injection, USP, shows a 1 gram/vial strength of powder for solution in a single dose vial. It states the product must be diluted for IV infusion or direct injection use. The label includes preparation instructions, storage conditions, and a cytotoxic agent warning. Manufactured for Intalere Choice by Baxter Healthcare Corporation.*

FDA Label Image

Cyclophosphamide Intalere Representative Carton Lbl 10019-936-01 Panel 2 (Image 07)

Packaging label for Cyclophosphamide for Injection, USP, 1 gram per vial, manufactured by Baxter Healthcare Corporation. The label states the product is for intravenous infusion or direct injection, must be diluted, and is a single-dose vial. The label includes the NDC 10019-936-01 and the branding Intalere Choice, with the product made in Germany.*

FDA Label Image

Cyclophosphamide Intalere Representative Container Lbl 10019-937-10 (Image 08)

Label for Cyclophosphamide injection, USP, 2 gram/vial as a powder for solution. The label states it is a cytotoxic agent for single dose use, sterile and non-pyrogenic for parenteral use. It provides instructions for IV infusion and direct injection, including volumes of diluent. Manufactured by Baxter Healthcare Corporation, made in Germany.*

FDA Label Image

Representative Cyclophosphamide Intelere Carton Lbl Ndc 10019-937-01 Panel 1 (Image 09)

Packaging label for Cyclophosphamide for Injection, USP, 2 gram per vial. The label indicates the product must be diluted for IV infusion or direct injection. It is a single dose vial labeled as a cytotoxic agent, sterile, non-pyrogenic, and for parenteral use. Manufactured by Baxter Healthcare Corporation and made in Germany. Instructions on dilution and storage are provided on the label.*

FDA Label Image

Representative Cyclophosphamide Intelere Carton Lbl Ndc 10019-937-01 Panel 2 (Image 10)

Packaging label for Cyclophosphamide for Injection, USP, 2 gram per vial, a prescription drug. The label states it must be diluted for IV infusion or direct injection use. It is a single-dose vial manufactured by Baxter Healthcare Corporation under the Intalere Choice brand, made in Germany. Includes NDC 10019-937-01 and a barcode.*

FDA Label Image

Representative Shipper Label 10019-935-01 (Image 11)

Packaging label for Cyclophosphamide for Injection, USP 500 mg by Baxter Healthcare Company under the Intalere Choice brand. The label indicates 120 packs, each containing one 500 mg single-dose vial. Storage instructions specify keeping at or below 25°C (77°F). The label includes NDC 10019-935-01 and features barcodes and placeholders for expiration date, lot number, and quantity.*

FDA Label Image

Representative Shipper Label 10019-936-01 (Image 12)

Packaging label for Cyclophosphamide for Injection, USP 1 g, from Intalere Choice by Baxter Healthcare Company. The label indicates storage at or below 25°C (77°F) and a package containing 120 packs of single-dose 1 g vials. The National Drug Code (NDC) shown is 10019-936-01. The label also includes barcodes, placeholders for expiration date, lot number, and quantity, as well as product and manufacturing information.*

FDA Label Image

Representative Shipper Label 10019-937-01 (Image 13)

Label for Cyclophosphamide for Injection, USP 2 g strength. The label indicates storage at or below 25°C (77°F) and shows packaging of 60 packs, each containing 1 single-dose vial of 2 g. Manufactured for Intalere Choice by Baxter Healthcare Corporation, Deerfield, IL. The label includes barcodes, lot number, expiration date placeholders, and NDC 10019-937-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.